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Abstract
Near-haploid chromosome numbers have been found in less than 1% of cytogenetically reported tumors, but seem to be
more common in certain neoplasms including the malignant cartilage-producing tumor chondrosarcoma. By a literature
survey of published karyotypes from chondrosarcomas we could confirm that loss of chromosomes resulting in
hyperhaploid-hypodiploid cells is common and that these cells may polyploidize. Sixteen chondrosarcomas were
investigated by single nucleotide polymorphism (SNP) array and the majority displayed SNP patterns indicative of a
hyperhaploid-hypodiploid origin, with or without subsequent polyploidization. Except for chromosomes 5, 7, 19, 20 and 21,
autosomal loss of heterozygosity was commonly found, resulting from chromosome loss and subsequent duplication of
monosomic chromosomes giving rise to uniparental disomy. Additional gains, losses and rearrangements of genetic
material, and even repeated rounds of polyploidization, may affect chondrosarcoma cells resulting in highly complex
karyotypes. Loss of chromosomes and subsequent polyploidization was not restricted to a particular chondrosarcoma
subtype and, although commonly found in chondrosarcoma, binucleated cells did not seem to be involved in these events.
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Introduction
Chondrosarcomais the collective term for a group ofbone tumors
characterized by hyaline cartilage differentiation and otherwise
heterogeneous morphological and clinical features [1]. Based on
morphology four subtypes can be recognized. By far, the most
common variant is conventional chondrosarcoma, which may
originate from the medullar cavity (central) or the surface of the
bone (peripheral) [2]. Less frequently encountered subtypes include
dedifferentiated, mesenchymal and clear cell chondrosarcomas.
When resectable, the prognosis is excellent. Inoperable or metastatic
tumorsare,however,generallylethalasthereiscurrentlynoeffective
chemotherapyandthetumorsarelargelyinsensitivetoradiotherapy.
Histological grade is the best predictor of clinical course, but the
discrimination between low-grade and high-grade lesions is
influenced by variability among observers [3,4]. Cytogenetic and
molecular genetic analyses have shown that chondrosarcomas
display chromosome numbers ranging from hyperhaploid to
hyperhexaploid [5,6]. Some tumors harbor related clones of two
ploidy levels, suggesting that chondrosarcoma cells may polyploidize
to the extent of duplicating their entire set of chromosomes, most
probably trough a single event. We have previously identified
genomic changes that support loss of chromosomes and subsequent
polyploidization in neoplastic chondrocytes by using cytogenetics
and array comparative genomic hybridization (CGH) [7]. However,
as the two chromosomal homologues cannot be discriminated by
these techniques it has not been possible to ascertain whether clones
with more than 46 chromosomes arise through polyploidization of
an originally hyperhaploid-hypodiploid clone or by other mecha-
nisms. To determine genomic aberrations and mechanisms for
aneuploidization in chondrosarcoma we have here used single
nucleotide polymorphism (SNP) array analysis, which allows for the
simultaneous detection of DNA copy number and loss of
heterozygosity (LOH) pattern. We have also performed a literature
survey of published karyotypes from chondrosarcomas. Further-
more, by combining immunofluorescence (IF) and fluorescence in
situ hybridization (FISH) analyses we have evaluated if binucleated
cells, which are commonly found in neoplastic cartilage [1], are
involved in the polyploidization of chondrosarcoma cells.
Results
Published data on cytogenetic alterations in
chondrosarcoma include loss of chromosomes and signs
of polyploidization
A survey of published karyotypes from chondrosarcomas
showed cytogenetic alterations (excluding 45,X,-Y) in 138 tumors
(Fig. 1). Less than 46 chromosomes were found in 49 cases, 8 of
which were hyperhaploid. In 9 of the hyperhaploid-hypodiploid
tumors a corresponding doubled clone was detected. Of 89 tumors
with 46 or more chromosomes, 27 cases displayed rearranged
chromosomes in $2 copies and/or doubled clones. As rearranged
chromosomes in $2 copies could result from duplication of all
chromosomes their presence may indicate that the cells have
polyploidized.
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Sixteen chondrosarcomas were investigated by SNP array
analysis. Chromosomal aberrations were detected in all cases
and the imbalances agreed well with previous array CGH and
cytogenetic findings (Figs. S1, S2, S3, S4) [7]. In most cases, the
majority of the autosomes displayed LOH resulting from loss of
chromosomes or uniparental disomy (UPD) (Fig. 2).
SNP array analysis reveals that chromosomes 5, 7, 19, 20
and 21 rarely show loss of heterozygosity
Chromosomes 5, 7, and 20 displayed regions which never were
monosomic whereas chromosomes 19 and 21 were lost in only one
case each (Fig. 2). The genomic regions 1.05–1.40 Mb, 7.56–
8.07 Mb, 9.67–9.91 Mb, 22.39–22.85 Mb, 29.46–30.27 Mb,
32.12–32.92 Mb, 34.73–34.85 Mb, 34.87–35.15 Mb, 36.14–
37.52 Mb, 37.63–38.07 Mb, 38.85–39.70 Mb, 40.23–41.47 Mb
and 44.41–44.43 Mb in chromosome 5, pter-20.07 Mb, 23.23–
54.74 Mb, 55.35–74.03 Mb, 108.16–109.18 Mb and 127.16–
130.32 Mb in chromosome 7, and 22.43–32.37 Mb in chromo-
some 20 were not deleted in any case. Genomic material was lost
from chromosomes 5, 7, 19, 20 and/or 21 in four to 13 of 138
published chondrosarcomas with aberrant karyotypes and in none
to three of the eight published near-haploid chondrosarcomas,
agreeing well with our SNP array results. Thus, chromosomes 5, 7,
19, 20 and 21 rarely displayed LOH and the vast majority of
cytogenetically investigated chondrosarcomas showed at least two
copies of these chromosomes.
Genomic aberrations support polyploidization of
chondrosarcoma cells
Based on cytogenetic findings, the ploidy levels of the SNP array
investigated tumors ranged from hyperhaploid to hypopentaploid
(Fig. 3, Table S1). Cases 1, 4, 7, 8, 10 and 11 presented
hyperhaploid-hypodiploid clones with retained heterozygosity for
disomic chromosomes and structural rearrangements in single
copies (Figs. S1, S2, S3, Table S1). Cases 3 and 12 showed
hypodiploid and hyperhaploid clones, respectively, together with
polyploid clones. SNP array cannot distinguish between the
original and polyploidized clones but in both cases the SNP array
results were in agreement with either or both of the karyotypic
clones (Figs. S1 and S3, Table S1). Case 14 displayed a
hypodiploid clone with mono- and disomic chromosomes (Fig.
S4, Table S1). The majority of disomic chromosomes showed
retained heterozygosity and four chromosomes displayed UPD.
Structurally rearranged chromosomes were found in a single
copy. Cases 6 and 13 showed hyperdiploid chromosome
numbers, frequent LOH for disomic chromosomes and two
maternal and two paternal alleles for the vast majority of
tetrasomic chromosomes (Figs. S2 and S4, Table S1). Single
copies of structurally rearranged chromosomes were detected in
case 6 and in a minor clone in case 13. In cases 5 and 15, SNP
array analysis detected hypodiploid cells whereas cytogenetic
analysis showed cells with the doubled number of chromosomes
as well as further changes (Figs. S2 and S4, Table S1). No
rearranged chromosomes were found in case 5. In case 15, many
chromosomal rearrangements were present in two copies. Case 9
Figure 1. Ploidy levels of cytogenetically analyzed chondrosarcomas of bone. To date, 138 chondrosarcomas of bone with an aberrant
karyotype (excluding myxoid chondrosarcomas and 45,X,-Y) have been published (Mitelman Database of Chromosome Aberrations and Gene Fusions
in Cancer: http://cgap.nci.nih.gov/Chromosomes/Mitelman June 1, 2010). The ploidy levels vary from hyperhaploid to hyperhexaploid. In 39 of the
cases rearranged chromosomes in at least two copies and/or a doubled clone were found, supporting polyploidization of chondrosarcoma cells.
doi:10.1371/journal.pone.0024977.g001
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or three copies, LOH for di- and trisomic chromosomes, and
retained heterozygosity for genomic regions present in four to six
copies (Fig. S3, Table S1). This combination of aberrations
suggests that an original hypodiploid cell polyploidized more than
one time (Fig. 3). In contrast to the other 14 cases, the vast
majority of chromosomes in the near-triploid cases 2 and 16
displayed retained heterozygosity. This is most likely explained by
polyploidization of diploid cells, followed by whole chromosome
losses and acquisition of complex aberrations (Figs. S1 and S4,
Table S1). In case 2, cytogenetic analysis also detected a related,
hypopentaploid clone. The vast majority of rearranged chromo-
somes in cases 2 and 16 were present in single copies. To
summarize, except for the two cases which seemed to have
polyploidized from a diploid cell the majority of chondrosarco-
mas displayed SNP array results suggestive of a hyperhaploid-
hypodiploid origin, with or without subsequent polyploidization
(Fig. 3). After polyploidization the cells may be affected by further
gains, losses and rearrangements of genetic material and
polyploidization may be repeated.
Figure 2. Genomic aberrations detected in 16 chondrosarcomas. Genomic loss, uniparental disomy (UPD) and gain of one or two copies
identified by SNP array analysis are displayed for all autosomes. Loss of heterozygosity resulting from deletion or UPD was frequently found, except
for chromosomes 5, 7, 19, 20 and 21. Detailed information on all aberrations affecting each individual case is shown in Figs. S1, S2, S3, S4. The
imbalance map was created using the freely available software Genome Wide Viewer (http://www.well.ox.ac.uk/,jcazier/GWA_View.html).
doi:10.1371/journal.pone.0024977.g002
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hyperhaploid-hypodiploid origin
The majority of the SNP array investigated chondrosarcomas were
of the central conventional type, one case was a peripheral
conventional chondrosarcoma and three were dedifferentiated
chondrosarcomas (Fig. 3). The low number of peripheral conven-
tional and dedifferentiated tumors precluded any comparison with
regard to differences in chromosome number or type of aberration
between the subtypes. There was no apparent difference in patient
outcome between cases in which polyploidization was detected and
casesin which onlya hyperhaploid orhypodiploidclone wasdetected
(Fig. 3, Table S1). CDKN2A was homozygously lost in eight cases and
hemizygouslydeleted in six cases (Fig. 3, Figs. S1, S2, S3, S4). In these
14 cases, SNP patterns indicative of a hyperhaploid-hypodiploid
origin, with or without subsequent polyploidization were detected.
Binucleated chondrocytes do not seem to give rise to
mononucleated polyploid cells
To investigate the involvement of binucleated chondrocytes in
polyploidization, ploidy levels of both mono- and binucleated
Figure 3. Inferred polyploidization events of hyperhaploid-hypodiploid chondrosarcoma cells affected by CDKN2A deletions.
Polyploidization of hyperhaploid-hypodiploid chondrosarcoma cells was supported by the combined SNP array and cytogenetic findings.
Hyperhaploid-hypodiploid clones were detected in eleven cases. In four of these and in five additional cases chromosome aberrations supporting
polyploidization was found. Polyploidization may occur more than one time and the cells may be affected by further rearrangements, gains and
losses of genetic material. In case 14, a hypodiploid chromosome number was detected and uniparental disomy was shown for several of the disomic
chromosomes. The detected pattern of aberrations in this case suggested a potential developmental step with duplication of some monosomic
chromosomes and did not support polyploidization of a hyperhaploid cell. In cases 2 and 16, the detected pattern of preserved heterozygosity for the
vast majority of chromosomes indicates that the tumor cells never had been hyperhaploid or hypodiploid and that polyploidization affected diploid
cells with both parental alleles retained. In these two cases CDKN2A was not affected by deletion, whereas in the remaining cases the gene was hemi-
or homozygously lost. Cases in which clones of two ploidy levels were detected are indicated by asterisks.
doi:10.1371/journal.pone.0024977.g003
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normal cartilage. Combined IF and FISH analyses showed that
binucleated chondrocytes represented 1–10% of the investigated
cells, irrespective of their ploidy level, and that the two nuclei in
binucleated cells consistently showed the same ploidy level (Fig. 4,
Table S2). In chondrosarcomas, diploid, hypodiploid and hyper-
triploid nuclei were found. Cells with diploid nuclei likely represent
normal cells present in the tumor sample. All nuclei of normal
cartilage were diploid, excluding that the binucleated normal
cartilage cells gave rise to mononucleated haploid or polyploid cells.
Discussion
A chromosome number in the near-haploid range is a rare
phenomenon in neoplasia, described in less than 1% of all
cytogenetically reported tumors [5]. It has primarily been found
in hematologic malignancies and in a few subtypes of solid tumors,
including chondrosarcoma [5,7,8]. We here show that hyperha-
ploid-hypodiploid chondrosarcoma cells often polyploidize and
subsequently may be affected by further gains, losses and
rearrangements of genetic material and that polyploidization may
occur more than one time. The majority of the autosomes
frequently displayed LOH as a result of chromosome loss and, in
some cases, subsequent duplication of the remaining homolog
giving rise to UPD. It is obvious that loss of chromosomes is
pathogenetically important in chondrosarcoma but bearing in mind
the size of the lost regions it is not possible to speculate on the
importance of individual genes for tumor development. Chromo-
somes 5, 7, 19, 20 and 21 nearly always displayed retained
heterozygosity, which is in line with previously published cytoge-
netic information [5]. Why these particular chromosomes are
retained and why the remaining autosomes are frequently lost
remains elusive. It is notable that a similar pattern, albeit involving
other chromosomes, is seen in hyperhaploid-hypodiploid acute
lymphoblastic leukemia (ALL) [9], suggesting that retention of
heterozygosity for certain chromosomes and loss of others may be a
general phenomenon in tumors with less than 46 chromosomes.
One possibility is that monoallelic gene expression is involved in the
selection of lost and retained genomic regions in chondrosarcoma.
The expression of about 1% of human genes is estimated to be
affected by parental imprinting and these genes have been predicted
by computational analysis to be present in all autosomes [10]. To
date, imprinted genes have been confirmed in chromosomes 1, 6, 7,
11, 14, 15, 18 and 20. In addition, autosomal genes have been
shown to display monoallelic expression due to random inactivation
of maternal or paternal alleles, i.e. some cells express the maternal
allele and other cells express the paternal allele; a pattern of
expressionthatismaintained indescendingcells[11].Therecurrent
pattern of chromosome aberrations in chondrosarcoma may hence
be attributed, at least partially, to allelic differences in gene
expression.
It has previously been shown that polyploidization of chondro-
sarcoma cells can occur in peripheral chondrosarcoma [6,8]. As
the majority of the present cases were represented by central
conventional and dedifferentiated chondrosarcomas it is evident
that polyploidization of an original hyperhaploid-hypodiploid cell
is not restricted to a particular subtype. Although based on an
admittedly limited number of cases, there was no obvious
difference in patient outcome between cases which displayed a
sole hyperhaploid-hypodiploid clone and cases which also showed
a duplicated clone. Thus, polyploidization is detected in all
chondrosarcoma subtypes sufficiently analyzed to date and does
not seem to be associated with progression of the disease.
Polyploidization has been demonstrated to occur during normal
liver growth through cytokinesis failure in hepatocytes, giving rise
to binucleated cells with diploid nuclei and subsequently to
mononucleated tetraploid cells [12]. In chondrosarcoma, binucle-
ated cells are commonly seen, but it is not known if these cells can
give rise to mononucleated haploid or polyploid cells [1]. In the
present study, the normal cartilage cells always displayed diploid
Figure 4. Ploidy levels of mono- and binucleated chondrocytes.
Combined immunofluorescence and fluorescence in situ hybridization
analyses were used to detect the ploidy levels of mono- and
binucleated chondrocytes. To visualize individual cells a plasma
membrane marker was detected by a fluorescently labeled antibody
(green). Centromeric probes specific for chromosomes known to be
monosomic (pink) and disomic (yellow) in hypodiploid cells and
consequently disomic (pink) and tetrasomic (yellow) in hypertriploid
cells were used for detection of ploidy levels. (A) Normal diploid nuclei
as well as (B) hypodiploid nuclei are shown in binucleated cells (case
17). Mononuclear cells display (C) hypodiploid, (D) normal and
hypertriploid nuclei (cases 18 and 15, respectively). The proportion of
binucleated chondrocytes was 1–10% of all cells investigated with
normal, hypodiploid and hypertriploid nuclei (Table S2). In binucleated
cells both nuclei displayed the same ploidy level.
doi:10.1371/journal.pone.0024977.g004
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that binucleated normal chondrocytes did not give rise to
mononucleated haploid or polyploid cells in our in vitro system.
This could indicate that the same is true for chondrosarcoma cells
and that polyploidization does not involve binucleated cells.
The concomitant detection of hyperhaploid-hypodiploid cells
and the corresponding duplicated clones demonstrates that
chondrosarcoma cells are initially affected by extensive loss of
whole chromosomes followed by polyploidization. In some cells
further genetic alterations occur. Using SNP array methodology,
the previously unclear issue of how clones with more than 46
chromosomes form has thus been resolved (Fig. 3). Based on the
present results and published cytogenetic information (Fig. 1),
hyperhaploid chondrosarcomas do not seem to represent a
separate group distinct from hypodiploid tumors. The mechanism
behind the initial chromosome loss could therefore be the same in
all chondrosarcomas. In similarity with hyperhaploid-hypodiploid
ALL which commonly display loss of CDKN2A [13], all the present
hyperhaploid-hypodiploid chondrosarcomas showed deletion of
this gene. Previous reports have demonstrated lack of CDKN2A
specifically in high-grade chondrosarcomas and suggested that this
deficiency affects cell viability and proliferation [14,15]. In the
present study, all but one of the investigated tumors were of high
grade. The majority displayed hyperhaploid-hypodiploid chromo-
some numbers or polyploidized clones with a hyperhaploid-
hypodiploid origin. Many tumors displayed monosomy 9, or loss
of chromosome arm 9p, with targeted deletion of CDKN2A in the
remaining homologue resulting in complete absence of this gene.
In this context it is interesting to note that lack of CDKN2A has
been shown to induce supernumerary centrosomes through
centriole pair splitting [16]. Cells that subsequently enter mitosis
with more than two centrosomes may divide either through a
pseudo-bipolar mitotic division or, more rarely, a multipolar
mitotic division [16,17,18]. Both events can result in unequal
segregation of genomic material. Cells reorienting from a
multipolar to a bipolar state during metaphase-anaphase transition
have been shown to survive despite having undergone chromo-
somal missegregation events, and are capable to again enter
mitosis [17,18]. Combined with selection for particular chromo-
somes, such cell divisions could create the hyperhaploid-hypodip-
loid clones detected in the present study. In cells affected by
polyploidization not only the chromosomes but also the centro-
somes have been duplicated. The disrupted chromosomal
segregation observed in the current tumors following polyploidiza-
tion may thus be attributed to acquired supernumerary centro-
somes and subsequent pseudo-bipolar divisions [19], similar to the
mechanisms by which polyploid hepatocytes recently have been
shown to reduce their ploidy and generate aneuploid daughter
cells [20].
In conclusion, we found that the majority of chondrosarcomas
initially were affected by loss of chromosomes and that the pattern
of lost and retained chromosomes was recurrent. Chromosomal
loss was often followed by duplication of the entire genome. After
polyploidization the cells may be affected by further gains, losses
and rearrangements of genetic material, and even repeated rounds
of polyploidization, creating highly complex karyotypes. Neither
loss of chromosomes nor polyploidization was restricted to a
particular chondrosarcoma subtype.
Materials and Methods
Ethics statement
All samples were obtained after informed consent and the study
has been approved by the Lund University Ethics Review Board.
Patient information and tumor samples
Tumors from 18 patients with skeletal chondrosarcoma, treated
at the Departments ofOrthopedicsat the Ska ˚ne University Hospital
or the Karolinska Hospital, Sweden, were included in the study.
Sixteen of the tumors were selected for SNP array analysis based on
previous array CGH findings showing an aberrant genomic profile
whichcorrelatedwellwithresultsobtainedbychromosome banding
[7]. The correlation between cytogenetic and array CGH findings
was used to ensure tumor representation of the DNA studied. The
tumors were not selected based on the types of genomic aberrations
present in the samples. Two tumors lacking suitable material for
SNP array analysis were included for FISH analysis. The patients
encompassed seven women and eleven men, with a median age of
69 years. Fourteen tumors were diagnosed as conventional and four
as dedifferentiated chondrosarcoma. The tumors were located in
theribs (7),femur(5),tibia(1),foot (1),pelvis(1),scapula(1),sternum
(1) and humerus (1). Based on radiographic appearance, twelve
tumors were classified as central, one as peripheral, and five were of
unclassifiable origin. The sizes of the tumors ranged from 4 to
20 cm; information was not available in one case. Using a three-
grade scale, one tumor was classified as low-grade (grade 1) and the
rest as high-grade (twelve grade 2 and five grade 3) chondrosarco-
mas according to the Evans grading scheme [21]. Follow-up ranged
from 6 to 144 months (median 79 months). One patient was lost to
follow-up. Of the remaining patients six developed metastases and
three oftheseandtwoadditionalpatients died from theirdisease.G-
banding karyotypes were available in all cases. Detailed patient
information can be found in Table S1.
Cytogenetic data from the literature
To obtain further information on the frequency of haploidiza-
tion and polyploidization in chondrosarcoma, as well as the
distribution of modal chromosome numbers, we surveyed
published karyotypes available in the Mitelman Database of
Chromosome Aberrations and Gene Fusions in Cancer (2010) [5].
Ploidy levels were defined as described in ISCN 2009 [22].
Whole genome DNA copy number and loss of
heterozygosity analyses
SNP array analysis was used for combined DNA copy number
and LOH investigation in cases 1–16. DNA previously extracted for
array CGH was used for the present analysis. The DNA had been
extracted from fresh frozen tumor biopsies using the DNeasy Tissue
Kit including the optional RNaseH treatment, according to the
manufacturer’s instructions (Qiagen, Valencia, CA, USA). Quality
and concentration of the extracted DNA were ascertained using a
NanoDrop ND-1000 (Thermo Fisher Scientific Inc., Waltham,
MA, USA). Tumor DNA was hybridized onto Illumina Human
Omni-Quad v1.0 BeadChip or Human CNV370-Quad v3.0
BeadChip (Illumina, San Diego, CA, USA), containing 1.2 million
and 370,000 markers, respectively, following standard protocols
supplied by the manufacturer. Data were extracted from the
GenomeStudio software (Illumina), and subsequently normalized
and segmented using thresholded quantile normalization (tQN) and
BAFsegmentation, respectively [23,24]. Base pair positions are
indicated according to the NCBI build 36 (hg18). SNP array data
have been deposited in the Gene Expression Omnibus (GEO)
database, www.ncbi.nlm.nih.gov/geo (accession no. GSE25985).
Combined immunofluorescence and interphase
fluorescence in situ hybridization analysis
The mouse monoclonal antibody pan Cadherin (ab22744,
5 mg/ml, Abcam, Cambridge, UK), detected by FITC-conjugated
Aneuploidy in Chondrosarcoma
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was used to visualize the plasma membrane of tumor cells in case
15, and in two additional chondrosarcomas without suitable
material for SNP array analysis (cases 17 and 18) as well as in
normal cartilage cells. The ploidy levels of the respective nuclei
were determined by manually counting the number of centromeric
probes specific for chromosomes known to be monosomic and
disomic in hypodiploid cells and consequently disomic and
tetrasomic in hypertriploid cells (Vysis, Downers Grove, IL,
USA). In case 15, probes for centromeres 10 and 18 were used. In
cases 17 and 18, as well as in normal cartilage, probes for
centromeres 2 and 10 were used. IF and FISH analyses were
performed as described with concurrent probe and target DNA
denaturation at 85uC for 10 min [25].
Supporting Information
Figure S1 SNP array findings in cases 1–4. Genomic loss,
gain, uniparental disomy (UPD) and normal copy numbers are
displayed for all autosomes in cases 1–4. Amplification denotes regions
represented by more than four chromosomal copies. The imbalances
maps were created using the freely available software Genome Wide
Viewer (http://www.well.ox.ac.uk/,jcazier/GWA_View.html).
(TIF)
Figure S2 SNP array findings in cases 5–8. Genomic loss,
gain, uniparental disomy (UPD) and normal copy numbers are
displayed for all autosomes in cases 5–8. Amplification denotes regions
represented by more than four chromosomal copies. The imbalances
maps were created using the freely available software Genome Wide
Viewer (http://www.well.ox.ac.uk/,jcazier/GWA_View.html).
(TIF)
Figure S3 SNP array findings in cases 9–12. Genomic loss,
gain, uniparental disomy (UPD) and normal copy numbers are
displayed for all autosomes in cases 9–12. Amplification denotes
regions represented by more than four chromosomal copies. The
imbalances maps were created using the freely available software
Genome Wide Viewer (http://www.well.ox.ac.uk/,jcazier/
GWA_View.html).
(TIF)
Figure S4 SNP array findings in cases 13–16. Genomic
loss, gain, uniparental disomy (UPD) and normal copy numbers
are displayed for all autosomes in cases 13–16. Amplification
denotes regions represented by more than four chromosomal
copies. The imbalances maps were created using the freely
available software Genome Wide Viewer (http://www.well.ox.ac.
uk/,jcazier/GWA_View.html).
(TIF)
Table S1 Clinical and cytogenetic features.
(DOC)
Table S2 Ploidy levels of mono- and binucleated
chondrosarcoma and cartilage cells detected by FISH.
(DOC)
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